Colgate-Palmolive (NYSE:CL) Shares Sold by Welch & Forbes LLC

Welch & Forbes LLC decreased its holdings in Colgate-Palmolive (NYSE:CL) by 5.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 92,915 shares of the company’s stock after selling 5,357 shares during the quarter. Welch & Forbes LLC’s holdings in Colgate-Palmolive were worth $6,368,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CL. Kentucky Retirement Systems acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $4,732,000. Cohen & Steers Inc. boosted its holdings in shares of Colgate-Palmolive by 0.5% in the third quarter. Cohen & Steers Inc. now owns 355,011 shares of the company’s stock valued at $23,768,000 after acquiring an additional 1,917 shares during the period. Standard Life Aberdeen plc boosted its holdings in shares of Colgate-Palmolive by 5.0% in the third quarter. Standard Life Aberdeen plc now owns 345,470 shares of the company’s stock valued at $23,130,000 after acquiring an additional 16,446 shares during the period. Legal & General Group Plc boosted its holdings in shares of Colgate-Palmolive by 4.6% in the third quarter. Legal & General Group Plc now owns 4,314,368 shares of the company’s stock valued at $288,821,000 after acquiring an additional 190,876 shares during the period. Finally, Morgan Stanley boosted its holdings in shares of Colgate-Palmolive by 15.0% in the third quarter. Morgan Stanley now owns 7,212,524 shares of the company’s stock valued at $482,879,000 after acquiring an additional 941,008 shares during the period. 74.63% of the stock is currently owned by institutional investors.

In other Colgate-Palmolive news, CEO Ian M. Cook sold 16,000 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $66.72, for a total value of $1,067,520.00. Following the completion of the transaction, the chief executive officer now owns 1,146,793 shares in the company, valued at $76,514,028.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Justin Skala sold 92,643 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $70.78, for a total value of $6,557,271.54. Following the completion of the transaction, the vice president now owns 163,653 shares of the company’s stock, valued at approximately $11,583,359.34. The disclosure for this sale can be found here. Insiders sold 335,211 shares of company stock valued at $23,724,495 in the last quarter. 1.14% of the stock is currently owned by company insiders.

Several research firms have recently weighed in on CL. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a report on Wednesday, May 1st. ValuEngine raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, May 13th. Morgan Stanley increased their price objective on Colgate-Palmolive from $62.00 to $68.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Macquarie increased their price objective on Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, April 29th. Finally, Jefferies Financial Group upped their price target on Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a research note on Monday, April 29th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $69.69.

Shares of Colgate-Palmolive stock traded down $0.55 during trading hours on Friday, hitting $71.20. 1,941,506 shares of the company were exchanged, compared to its average volume of 3,688,568. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $73.10. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74. The stock has a market capitalization of $61.60 billion, a PE ratio of 23.97, a price-to-earnings-growth ratio of 4.69 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.67 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.86 billion. Colgate-Palmolive had a negative return on equity of 3,730.37% and a net margin of 15.08%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.74 earnings per share. As a group, equities research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were given a $0.43 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date was Wednesday, April 17th. This represents a $1.72 annualized dividend and a yield of 2.42%. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Sundance Herald and is owned by of Sundance Herald. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://sundanceherald.com/2019/05/24/colgate-palmolive-cl-holdings-cut-by-welch-forbes-llc.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: Percentage Decliners

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply